Dr Shermarke Hassan
Contact information
Research groups
Shermarke Hassan
Epidemiologist
Shermarke joined IDDO in January 2023 as an epidemiologist. He has a background in medicine (BSc) and epidemiology (MSc, PhD). Previously, he has been involved in the design, execution and analysis of clinical and observational studies in the area of haemophilia (a rare bleeding disorder) and COVID-19. In his current role, he is involved in the data curation and statistical analysis of COVID-19 data.
Recent publications
-
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET Cohort
Hassan S. et al, (2024), Blood Advances
-
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis
Arcudi S. et al, (2024), Blood Advances
-
Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review.
Wilson J. et al, (2023), BMJ open, 13
-
EFFECT OF DNA METHYLATION ON INHIBITOR DEVELOPMENT IN HEMOPHILIA A PATIENTS TREATED WITH FVIII CONCENTRATES
Chand H. et al, (2023), HAEMOPHILIA, 29, 27 - 27
-
FVIII-SPECIFIC IGA ANTIBODIES AND HISTORY OF HEPATITIS C VIRUS INFECTION: A CROSS-SECTIONAL NATIONWIDE STUDY IN PERSONS WITH HEMOPHILIA A
Oomen I. et al, (2023), HAEMOPHILIA, 29, 25 - 25